Cel-Sci
CVM
#10616
Rank
โ‚ฌ17.58 M
Marketcap
1,01ย โ‚ฌ
Share price
-4.92%
Change (1 day)
-87.66%
Change (1 year)

EPS for Cel-Sci (CVM)

EPS in 2026 (TTM): -4,47ย โ‚ฌ

According to Cel-Sci 's latest financial reports the company's current EPS (TTM) is -4,37ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -5,44ย โ‚ฌ an increase over its 2024 EPS that were of -13,28ย โ‚ฌ.

EPS history for Cel-Sci from 1996 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-4,47ย โ‚ฌ-17.91%
2025-5,44ย โ‚ฌ-59.05%
2024-13,28ย โ‚ฌ-30.09%
2023-19,00ย โ‚ฌ-16.09%
2022-22,64ย โ‚ฌ-3.33%
2021-23,42ย โ‚ฌ9.76%
2020-21,34ย โ‚ฌ15.49%
2019-18,48ย โ‚ฌ-62.03%
2018-48,67ย โ‚ฌ2.19%
2017-47,63ย โ‚ฌ-22.78%
2016-61,68ย โ‚ฌ-77.45%
2015-273,52ย โ‚ฌ-13.14%
2014-314,90ย โ‚ฌ61.33%
2013-195,19ย โ‚ฌ-57.14%
2012-455,44ย โ‚ฌ-45.31%
2011-832,80ย โ‚ฌ-420%
2010260,25ย โ‚ฌ-112.9%
2009-2.017ย โ‚ฌ342.86%
2008-455,44ย โ‚ฌ-30%
2007-650,63ย โ‚ฌ-0%
2006-650,63ย โ‚ฌ150%
2005-260,25ย โ‚ฌ-0%
2004-260,25ย โ‚ฌ-75%
2003-1.041ย โ‚ฌ-54.29%
2002-2.277ย โ‚ฌ-31.37%
2001-3.318ย โ‚ฌ15.91%
2000-2.863ย โ‚ฌ-12.89%
1999-3.287ย โ‚ฌ-29.73%
1998-4.677ย โ‚ฌ-26%
1997-6.320ย โ‚ฌ-13.79%
1996-7.331ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,58ย โ‚ฌ-273.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
12,56ย โ‚ฌ-387.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-1,99ย โ‚ฌ-54.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-20,65ย โ‚ฌ 372.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
1,19ย โ‚ฌ-127.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
-1,50ย โ‚ฌ-65.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-0,15ย โ‚ฌ-96.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-1.420ย โ‚ฌ 32,375.20%๐Ÿ‡บ๐Ÿ‡ธ USA